Abstract
Oxaliplatin (L-OHP) is a standard treatment drug for colorectal cancer (CRC), but acquired drug resistance limits the outcome of patients. We investig......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
